Probiotics for Preterm Infants

After completing this article, readers should be able to: 1. Describe some of the known functions of the microbiota of the intestinal tract. 2. Define probiotics and explain how they have been used. 3. Review current understanding of the mechanisms of probiotic action. 4. Explain how probiotics might provide benefits to the preterm infant, including the prevention of necrotizing enterocolitis. A better understanding of the intestinal ecosystem in sick preterm neonates may hold the key to prevention of several important diseases as well as improvement of short- and long-term health. The intestinal ecosystem is composed of three primary components that interact closely: host cells, nutrients, and microflora. Recently, a fourth component has been recognized to be important as it pertains to pediatric medicine, especially in neonatology: How the changes in intestinal microflora during maturation affect the developing intestine and how these interact with the changing nutrient environment. Interaction between these components affects numerous processes that are mutually beneficial to the microorganisms and the host. New knowledge of these interactions and the effects of maintaining normal homeostasis or perturbing the interactions should be highly applicable for disease prevention both during infancy and later life. In this article, we present information about the intestinal microflora, how they interact with the intestine and the nutritional environment (“cross talk”), what can go wrong (especially as pertains to the preterm infant), and the potential use of probiotics. ### Functional Aspects The microflora of the adult human is found primarily in the colon and distal mall intestine and consists of more than 1013 microorganisms (the “microbiota”), comprising nearly 500 species and nearly 2 million genes (the “microbiome”). For the most part, this is a mutually beneficial relationship. The microbiota is a metabolically active entity that allows for the synthesis and breakdown of numerous dietary compounds and obviates the need for the host …

[1]  J. Bienenstock,et al.  Live Lactobacillus reuteri Is Essential for the Inhibitory Effect on Tumor Necrosis Factor Alpha-Induced Interleukin-8 Expression , 2004, Infection and Immunity.

[2]  C. De Simone,et al.  DNA from probiotic bacteria modulates murine and human epithelial and immune function. , 2004, Gastroenterology.

[3]  L. Hooper,et al.  Bacterial contributions to mammalian gut development. , 2004, Trends in microbiology.

[4]  S. Salminen,et al.  Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges , 1996, Antonie van Leeuwenhoek.

[5]  I. Sanderson The innate immune system of the gastrointestinal tract. , 2003, Molecular immunology.

[6]  M. Millar,et al.  Probiotics for preterm infants? , 2003, Archives of disease in childhood. Fetal and neonatal edition.

[7]  V. Paul,et al.  Effects of Oral Lactobacillus GG on Enteric Microflora in Low-Birth-Weight Neonates , 2003, Journal of pediatric gastroenterology and nutrition.

[8]  Jeffrey I. Gordon,et al.  Angiogenins: a new class of microbicidal proteins involved in innate immunity , 2003, Nature Immunology.

[9]  C. Hoy The role of infection in necrotising enterocolitis , 2001 .

[10]  A. Young,et al.  Prokaryotic Regulation of Epithelial Responses by Inhibition of IκB-α Ubiquitination , 2000 .

[11]  R. Xavier,et al.  How to Get Along--Friendly Microbes in a Hostile World , 2000, Science.

[12]  J. Laman,et al.  Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. , 2000, Vaccine.

[13]  A. Hoyos Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. , 1999, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[14]  P. Panigrahi,et al.  Stool microflora in extremely low birthweight infants , 1999, Archives of disease in childhood. Fetal and neonatal edition.

[15]  J. H. I. Huis in't Veld,et al.  Overview of gut flora and probiotics. , 1998, International journal of food microbiology.

[16]  G. Perdigón,et al.  Immune system stimulation by probiotics. , 1995, Journal of dairy science.

[17]  H. Suomalainen,et al.  Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG. , 1995, Vaccine.

[18]  G. Barnes,et al.  Development of gut colonisation in pre-term neonates. , 1982, Journal of medical microbiology.